Investors

Date	Name	Title	Type	Shares Traded	Price Range
Dec 1, 2011	yancopoulos george	Officer	Automatic Sell	27,713	58.86 - 59.45
Nov 30, 2011	yancopoulos george	Officer	Automatic Sell	142,722	58.19
Nov 30, 2011	yancopoulos george	Officer	Option Execute	200,000	28.01
Nov 22, 2011	sing george l	Director	Option Execute	15,000	28.81
Nov 14, 2011	stahl neil	Officer	Option Execute	17,182	11.64
Oct 14, 2011	goldstein joseph l	Director	Automatic Sell	10,000	65.00
Oct 14, 2011	goldstein joseph l	Director	Option Execute	10,000	23.84
Oct 11, 2011	terifay robert j	Officer	Automatic Sell	7,214	64.98 - 65.34
Oct 10, 2011	terifay robert j	Officer	Automatic Sell	12,786	64.78
Oct 10, 2011	terifay robert j	Officer	Option Execute	29,372	21.34
Oct 4, 2011	goldberg murray a	Officer	Option Execute	13,749	9.49 - 13.00
Sep 21, 2011	brown michael s	Director	Automatic Sell	5,000	78.00
Sep 21, 2011	brown michael s	Director	Option Execute	5,000	9.17
Sep 21, 2011	goldberg murray a	Officer	Automatic Sell	4,200	67.00
Sep 20, 2011	goldstein joseph l	Director	Acquisition (Non Open Market)	10,000	n/a
Sep 14, 2011	ryan arthur f	Director	Disposition (Non Open Market)	32,145	64.85
Sep 14, 2011	ryan arthur f	Director	Option Execute	115,000	9.17 - 24.41
Sep 9, 2011	goldberg murray a	Officer	Automatic Sell	7,542	67.19 - 69.08
Sep 8, 2011	brown michael s	Director	Automatic Sell	5,000	74.00
Sep 8, 2011	brown michael s	Director	Option Execute	5,000	9.17
Showing 281-300 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.